Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ISF | has everyone get the money? | 25/10/11 | 2 | 5.5K | |||
|
|||||||
ISF | Ann: Removal from Official List COB 3/08/11 | 03/08/11 | 0 | 1.1K | |||
|
|||||||
ISF +OCP | Ann: Receipt of iSOFT proceeds and Net Assets per | 01/08/11 | 0 | 1.6K | |||
|
|||||||
ISF | Ann: Final Director's Interest Notice | 01/08/11 | 0 | 1.0K | |||
|
|||||||
ISF | how does this work? | 29/07/11 | 6 | 3.5K | |||
|
|||||||
ISF | Ann: Change of Director's Interest Notice | 29/07/11 | 0 | 980 | |||
|
|||||||
ISF | Ann: Court Approves Results of Scheme Meetings | 23/07/11 | 2 | 1.7K | |||
|
|||||||
ISF | Ann: Ceasing to be a substantial holder | 21/07/11 | 0 | 1.0K | |||
|
See All Discussions